e-learning
resources
Barcelona 2010
Sunday, 19.09.2010
Quality management for lung cancer patients
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Is the speed & likelihood of diagnosis of lung cancer influenced by referral origin?
A. Draper, A. Ho, S. Lovett, Y. E. Ong (London, United Kingdom)
Source:
Annual Congress 2010 - Quality management for lung cancer patients
Session:
Quality management for lung cancer patients
Session type:
E-Communication Session
Number:
290
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Draper, A. Ho, S. Lovett, Y. E. Ong (London, United Kingdom). Is the speed & likelihood of diagnosis of lung cancer influenced by referral origin?. Eur Respir J 2010; 36: Suppl. 54, 290
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Lung cancer: clinical presentation and specialist referral time
Source: Eur Respir J 2004; 24: 898-904
Year: 2004
Postoperative predicting value of lung function in patients with lung cancer – Fortune-telling or reality? Evaluation after surgical treatment
Source: Annual Congress 2011 - Lung function today and tomorrow II
Year: 2011
Smoking assessment & treatment in hospital: Are we providing ‘right care‘ and/or missing cannabis-smoking?
Source: Annual Congress 2011 - Anti-smoking interventions: prevention and treatment
Year: 2011
Is time from "referral to diagnosis" in lung cancer pathway affected by diagnostic test delays?
Source: International Congress 2015 – Quality management in lung cancer
Year: 2015
6-minute-walk in lung cancer – a new predictor for response and the performance status?
Source: Annual Congress 2009 - Various diagnostic aspects in lung cancer and rare lung tumours
Year: 2009
A retrospective study on flexible bronchoscopic yield in the diagnosis of lung cancer – is it operator dependent?
Source: Annual Congress 2009 - Various diagnostic aspects in lung cancer and rare lung tumours
Year: 2009
Detection of lung cancer on CXR – A comparison of radiologist‘s performance
Source: Annual Congress 2010 - Quality management for lung cancer patients
Year: 2010
Nursing personal & respiratory cancer care: field experiences of Indian cancer N.G.O.
Source: Annual Congress 2009 - Epidemiology and management of lung cancer
Year: 2009
Clinical pattern of extrapulmonary tuberculosis (EPT) as observed at a teaching hospital in India – are we missing them?
Source: Annual Congress 2009 - Pulmonary infections
Year: 2009
Current screening programs for lung cancer – Are inclusion criteria too rigorous to identify asymptomatic patients?
Source: Annual Congress 2011 - Epidemiology of lung cancer and screening
Year: 2011
Diagnosing lung cancer: is the 28 day rule appropriate?
Source: Eur Respir J 2004; 24: Suppl. 48, 298s
Year: 2004
Does raising awareness of lung cancer symptoms in primary care alter referral patterns?
Source: Annual Congress 2011 - Quality management for lung cancer patients
Year: 2011
Survival outcomes in advance non-small cell lung cancer – A developing country scenario
Source: Annual Congress 2011 - Quality management for lung cancer patients
Year: 2011
CT screening for lung cancer: is it ready for prime time yet or how to enhance pre-test probability?
Source: International Congress 2017 – The latest in lung cancer
Year: 2017
Delays in the diagnosis and treatment of lung cancer: Can the length of time between the appearance of symptoms and diagnosis and treatment be shortened?
Source: Annual Congress 2010 - Quality management for lung cancer patients
Year: 2010
Is it useful CD4+CD103+/CD4+ ratio for the diagnosis of lung sarcoidosis?
Source: Annual Congress 2011 - Diagnosis and treatment of inflammatory respiratory diseases
Year: 2011
Delays in the diagnosis and treatment of primary lung cancer: are longer delays associated with advanced pathological stage?
Source: Annual Congress 2008 - Diagnostic aspects in thoracic oncology
Year: 2008
Doctors (drs) knowledge of diagnosing, investigating & managing pulmonary embolus (PE) in pregnancy?
Source: Annual Congress 2009 - Pulmonary embolism
Year: 2009
Six minute walk test (6MWT) in patients with diagnosis of lung cancer – Clinical value in physiological evaluation candidates for surgical treatment
Source: Annual Congress 2012 - Pre-operative evaluation in thoracic surgery
Year: 2012
Non-adherence to treatment decisions made at a lung cancer multi-disciplinary meetings – Causes and frequency
Source: Annual Congress 2010 - Quality management for lung cancer patients
Year: 2010
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept